The purpose of this report is to cover the definition, description, and forecast of the U.S. radiation dose management market. It involves deep dive analysis of market segmentation, which comprises of product type, application, and end user. The report also gives the deep insight on, and strategic analysis of, the key players of this market.
The U.S. radiation dose management market is expected to grow at a CAGR of 49.7% from 2015 to 2020.
In this report, the U.S. radiation dose management market has been classified on the basis of product type, application, and end user. Based on product type, the market has been segmented into services and software. Based on application, the market has been segmented into computed tomography, fluoroscopy, radiography & mammography, and nuclear medicine. Based on end user, the market has been segmented into hospitals, diagnostic centers, and research institutes & academic medical centers.
Software is the fastest-growing segment of the market, and is expected to grow at the highest CAGR of 50.3% from 2015 to 2020. Factors such as growing awareness among stakeholders, various industry initiatives taken for radiation dose management through various scientific and media reports, campaigns and safety programs, along with various government initiatives have led to the increased awareness among patients. The growing concern for the risk of over-exposure to radiations is another factor expected to drive the growth of the U.S. radiation dose management market.
The major companies operational in this market include Bayer AG (Germany), GE Healthcare (U.K.), PACSHealth, LLC (U.S.), and Sectra AB (Sweden). Other players includes QAELUM NV (Belgium), Philips Healthcare (Netherlands), FUJIFILM Holdings Corporation (Japan), Novarad Corporation (U.S.) Siemens Healthcare (Germany), Agfa HealthCare (Belgium), Toshiba Medical Systems Corporation (Japan), Bracco Imaging S.p.A (Italy), and McKesson Corporation (U.S.). These companies have adopted various strategies, such as mergers & acquisitions and partnerships, among others, to achieve growth in the U.S. radiation dose management market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging- and high-growth in the country and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to analyze the market, which in turn will help the firms in achieving a greater market share. Firms purchasing the report could use any one or combination of the below mentioned strategies for strengthening their market share.
- Market Penetration: Comprehensive information on top players in the S. radiation dose management market
- Market Diversification: Exhaustive information about new products, recent developments, and investments in the S. radiation dose management market
- S. radiation dose management market Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the U.S. radiation dose management market
Best Selling Reports :
U.S. Army Institute of Surgical Research – Pharmaceuticals & Healthcare – Deals and Alliances Profile